Sanofi (VIE:SANO)

Market Cap	92.55B -12.1%
Revenue (ttm)	48.92B +7.0%
Net Income	3.96B -56.6%
EPS	3.26 -55.6%
Shares Out	n/a
PE Ratio	23.38
Forward PE	8.75
Dividend	4.12 (5.25%)
Ex-Dividend Date	May 5, 2026

Volume	n/a
Open	77.87
Previous Close	76.25
Day's Range	76.25 - 77.87
52-Week Range	71.65 - 90.66
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for onc...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 74,846
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: SANO

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 29, 2026

Data Sources Report a data error